SG11201811579VA - Chemiluminescent substrates - Google Patents
Chemiluminescent substratesInfo
- Publication number
- SG11201811579VA SG11201811579VA SG11201811579VA SG11201811579VA SG11201811579VA SG 11201811579V A SG11201811579V A SG 11201811579VA SG 11201811579V A SG11201811579V A SG 11201811579VA SG 11201811579V A SG11201811579V A SG 11201811579VA SG 11201811579V A SG11201811579V A SG 11201811579VA
- Authority
- SG
- Singapore
- Prior art keywords
- brea
- south
- international
- kraemer
- boulevard
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
- C09K—MATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
- C09K11/00—Luminescent, e.g. electroluminescent, chemiluminescent materials
- C09K11/06—Luminescent, e.g. electroluminescent, chemiluminescent materials containing organic luminescent materials
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/531—Production of immunochemical test materials
- G01N33/532—Production of labelled immunochemicals
- G01N33/533—Production of labelled immunochemicals with fluorescent label
-
- C—CHEMISTRY; METALLURGY
- C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
- C09K—MATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
- C09K2211/00—Chemical nature of organic luminescent or tenebrescent compounds
- C09K2211/10—Non-macromolecular compounds
- C09K2211/1018—Heterocyclic compounds
- C09K2211/1025—Heterocyclic compounds characterised by ligands
- C09K2211/1029—Heterocyclic compounds characterised by ligands containing one nitrogen atom as the heteroatom
-
- C—CHEMISTRY; METALLURGY
- C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
- C09K—MATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
- C09K2211/00—Chemical nature of organic luminescent or tenebrescent compounds
- C09K2211/10—Non-macromolecular compounds
- C09K2211/1018—Heterocyclic compounds
- C09K2211/1025—Heterocyclic compounds characterised by ligands
- C09K2211/1029—Heterocyclic compounds characterised by ligands containing one nitrogen atom as the heteroatom
- C09K2211/1033—Heterocyclic compounds characterised by ligands containing one nitrogen atom as the heteroatom with oxygen
-
- C—CHEMISTRY; METALLURGY
- C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
- C09K—MATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
- C09K2211/00—Chemical nature of organic luminescent or tenebrescent compounds
- C09K2211/10—Non-macromolecular compounds
- C09K2211/1018—Heterocyclic compounds
- C09K2211/1025—Heterocyclic compounds characterised by ligands
- C09K2211/1029—Heterocyclic compounds characterised by ligands containing one nitrogen atom as the heteroatom
- C09K2211/1037—Heterocyclic compounds characterised by ligands containing one nitrogen atom as the heteroatom with sulfur
-
- C—CHEMISTRY; METALLURGY
- C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
- C09K—MATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
- C09K2211/00—Chemical nature of organic luminescent or tenebrescent compounds
- C09K2211/10—Non-macromolecular compounds
- C09K2211/1018—Heterocyclic compounds
- C09K2211/1025—Heterocyclic compounds characterised by ligands
- C09K2211/1029—Heterocyclic compounds characterised by ligands containing one nitrogen atom as the heteroatom
- C09K2211/104—Heterocyclic compounds characterised by ligands containing one nitrogen atom as the heteroatom with other heteroatoms
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Materials Engineering (AREA)
- Biomedical Technology (AREA)
- Hematology (AREA)
- Molecular Biology (AREA)
- Urology & Nephrology (AREA)
- Food Science & Technology (AREA)
- Microbiology (AREA)
- Medicinal Chemistry (AREA)
- Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Cell Biology (AREA)
- Biotechnology (AREA)
- Investigating Or Analysing Materials By The Use Of Chemical Reactions (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Abstract
INTERNATIONAL APPLICATION PUBLISHED UNDER THE PATENT COOPERATION TREATY (PCT) (19) World Intellectual Property 1#11101111 01E101011M 3E1 0 011110110110011111111101111011011# Organization International Bureau (10) International Publication Number (43) International Publication Date .....0\"\" WO 2018/006059 Al 04 January 2018 (04.01.2018) W I PO I PCT (51) International Patent Classification: (74) Agent: KOWALCHYK, Katherine, M.; Merchant & CO9K 11/06 (2006.01) CO7D 219/12 (2006.01) Gould P.C., P.O. Box 2903, Minneapolis, MN 55402-0903 (21) International Application Number: (US). PCT/US2017/040457 (81) Designated States (unless otherwise indicated, for every (22) International Filing Date: kind of national protection available): AE, AG, AL, AM, 30 June 2017 (30.06.2017) AO, AT, AU, AZ, BA, BB, BG, BH, BN, BR, BW, BY, BZ, CA, CH, CL, CN, CO, CR, CU, CZ, DE, DJ, DK, DM, DO, (25) Filing Language: English DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, HN, (26) Publication Language: English HR, HU, ID, IL, IN, IR, IS, JO, JP, KE, KG, KH, KN, KP, KR, KW, KZ, LA, LC, LK, LR, LS, LU, LY, MA, MD, ME, (30) Priority Data: MG, MK, MN, MW, MX, MY, MZ, NA, NG, NI, NO, NZ, 62/357,091 30 June 2016 (30.06.2016) US OM, PA, PE, PG, PH, PL, PT, QA, RO, RS, RU, RW, SA, SC, SD, SE, SG, SK, SL, SM, ST, SV, SY, TH, TJ, TM, TN, (71) Applicant: BECKMAN COULTER, INC. [US/US]; 250 TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, ZW. S. Kraemer Boulevard, Brea, CA 92821 (US). (84) Designated States (unless otherwise indicated, for every (72) Inventor; and kind of regional protection available): ARIPO (BW, GH, (71) Applicant: KOTI, Jaya, S. [US/US]; c/o Beckman Coul- GM, KE, LR, LS, MW, MZ, NA, RW, SD, SL, ST, SZ, TZ, ter, Inc., 250 South Kraemer Boulevard, Brea, CA 92821 UG, ZM, ZW), Eurasian (AM, AZ, BY, KG, KZ, RU, TJ, (US). TM), European (AL, AT, BE, BG, CH, CY, CZ, DE, DK, (72) Inventors: DE SILVA, Renuka; c/o Beckman Coulter, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LT, LU, LV, — Inc., 250 South Kraemer Boulevard, Brea, CA 92821 MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, = (US). EICKHOLT, Robert, A.; c/o Beckman Coulter, TR), OAPI (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, = Inc., 250 South Kraemer Boulevard, Brea, CA 92821 KM, ML, MR, NE, SN, TD, TG). _ (US). SANDISON, Mark, D.; c/o Beckman Coulter, Inc., = 250 South Kraemer Boulevard, Brea, CA 92821 (US). Published: SCHUMM, David, L.; c/o Beckman Coulter, Inc., 250 — with international search report (Art. 21(3)) South Kraemer Boulevard, Brea, CA 92821 (US). XIE, _ Wenhua; c/o Beckman Coulter, Inc., 250 South Kraemer = Boulevard, Brea, CA 92821 (US). = = = = (54) Title: CHEMILUMINESCENT SUBSTRATES = = = = = _ = 1-1 O\ In 4.0 3,5 ,0 * 4 ' I, 25 < :9: 2,0 a., 1 3 to 0.5 A B C D C0 V::+ 0 0 0,0 g 0 2 4 8 10 12 14 Day —.... FIG. 9C 1-1 0 ei (57) : Alkaline phosphatase chemiluminescent substrate formulations are provided exhibiting rapid incubation periods and 0 5 improved stability for use in immunoassays.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201662357091P | 2016-06-30 | 2016-06-30 | |
| PCT/US2017/040457 WO2018006059A1 (en) | 2016-06-30 | 2017-06-30 | Chemiluminescent substrates |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SG11201811579VA true SG11201811579VA (en) | 2019-01-30 |
Family
ID=59363247
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SG11201811579VA SG11201811579VA (en) | 2016-06-30 | 2017-06-30 | Chemiluminescent substrates |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US10703971B2 (en) |
| EP (1) | EP3478792B1 (en) |
| JP (3) | JP7426194B2 (en) |
| KR (1) | KR102411925B1 (en) |
| CN (1) | CN109642153B (en) |
| AU (1) | AU2017290887B2 (en) |
| CA (1) | CA3029241A1 (en) |
| MA (1) | MA45553A (en) |
| MX (1) | MX2019000213A (en) |
| SG (1) | SG11201811579VA (en) |
| WO (1) | WO2018006059A1 (en) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2017373945A1 (en) | 2016-12-07 | 2019-06-20 | Agenus Inc. | Antibodies and methods of use thereof |
| CN108562735A (en) * | 2018-02-05 | 2018-09-21 | 江苏泽成生物技术有限公司 | A kind of enzyme-catalyzed chemical luminescence substrate liquid of alkaline phosphatase and preparation method thereof |
| CN109490281A (en) * | 2018-10-18 | 2019-03-19 | 深圳天深医疗器械有限公司 | Chemoluminescent substrate and its application |
| CN114364987A (en) | 2019-07-03 | 2022-04-15 | 贝克曼库尔特有限公司 | Configurable wash process for sample analyzer |
| EP4010709A1 (en) | 2019-08-05 | 2022-06-15 | Beckman Coulter, Inc. | Methods for onboard dilutions using automated analyzer |
| CN112542306B (en) * | 2020-12-17 | 2022-12-30 | 华东理工大学 | Strong paramagnetic material based on monovalent metal ions, preparation method and application thereof |
| WO2022147370A1 (en) | 2020-12-31 | 2022-07-07 | Beckman Coulter, Inc. | Heated degassing dispenser |
| WO2024011149A1 (en) | 2022-07-05 | 2024-01-11 | Beckman Coulter, Inc. | Improved assay compositions and methods |
Family Cites Families (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4978614A (en) | 1988-10-26 | 1990-12-18 | Tropix, Inc. | Method of detecting a substance using enzymatically-induced decomposition of dioxetanes |
| US5112960A (en) | 1989-07-17 | 1992-05-12 | Bronstein Irena Y | Chemiluminescent 3-(substituted adamant-2'-ylidene) 1,2-dioxetanes |
| US5393469A (en) | 1992-03-20 | 1995-02-28 | Lumigen, Inc. | Polymeric phosphonium salts providing enhanced chemiluminescence from 1,2-dioxetanes |
| AU5373694A (en) | 1992-11-06 | 1994-06-08 | Ici New Zealand Ltd. | Dry water-dispersible glyphosate phytoactive formulation |
| CN1312252A (en) * | 1996-01-16 | 2001-09-12 | 鲁米根公司 | Intermediate of chemical compound generating chemical illumination when reacts with phosphatase |
| JP3169383B2 (en) * | 1996-01-16 | 2001-05-21 | ルミゲン インク | Compounds, compositions and methods for generating chemiluminescence with phosphatase enzymes |
| US5965736A (en) * | 1996-01-16 | 1999-10-12 | Lumigen, Inc. | Compositions and methods for generating red chemiluminescence |
| US5772926A (en) * | 1997-05-13 | 1998-06-30 | Lumigen, Inc. | Chemiluminescent reactions using dihydroxyaromatic compounds and heterocyclic enol phosphates |
| US5990224A (en) | 1997-09-18 | 1999-11-23 | Eastman Chemical Company | Stable low foam waterborne polymer compositions containing poly(alkyleneimines) |
| SE0100200D0 (en) * | 2001-01-24 | 2001-01-24 | Astrazeneca Ab | New film coating |
| ES2233876T3 (en) * | 2001-12-19 | 2005-06-16 | Astrazeneca Ab | NEW FILM COATING CONTAINING A COPYLIMYER METHYL ACRYLATE / METHYL METAL AND POLY (VINYL ACETATE). |
| SE0202353D0 (en) * | 2002-08-01 | 2002-08-01 | Astrazeneca Ab | New film coating |
| CN103153274B (en) * | 2010-10-04 | 2016-02-17 | 荷兰联合利华有限公司 | Skin aufhellung compositions |
| KR101772782B1 (en) | 2013-03-15 | 2017-08-29 | 아이리스 인터내셔널 인크. | Method and composition for staining and processing a urine sample |
-
2017
- 2017-06-30 JP JP2018568795A patent/JP7426194B2/en active Active
- 2017-06-30 US US16/313,438 patent/US10703971B2/en active Active
- 2017-06-30 WO PCT/US2017/040457 patent/WO2018006059A1/en unknown
- 2017-06-30 EP EP17740547.9A patent/EP3478792B1/en active Active
- 2017-06-30 SG SG11201811579VA patent/SG11201811579VA/en unknown
- 2017-06-30 CA CA3029241A patent/CA3029241A1/en active Pending
- 2017-06-30 MA MA045553A patent/MA45553A/en unknown
- 2017-06-30 CN CN201780050258.4A patent/CN109642153B/en active Active
- 2017-06-30 KR KR1020197003103A patent/KR102411925B1/en active IP Right Grant
- 2017-06-30 AU AU2017290887A patent/AU2017290887B2/en active Active
- 2017-06-30 MX MX2019000213A patent/MX2019000213A/en unknown
-
2022
- 2022-04-13 JP JP2022066314A patent/JP2022093395A/en not_active Withdrawn
-
2024
- 2024-04-05 JP JP2024061440A patent/JP2024083477A/en active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| CN109642153A (en) | 2019-04-16 |
| AU2017290887B2 (en) | 2021-08-05 |
| AU2017290887A1 (en) | 2019-01-24 |
| KR102411925B1 (en) | 2022-06-22 |
| EP3478792B1 (en) | 2023-12-13 |
| KR20190022857A (en) | 2019-03-06 |
| BR112018077252A2 (en) | 2019-04-02 |
| CN109642153B (en) | 2022-08-19 |
| JP2024083477A (en) | 2024-06-21 |
| MA45553A (en) | 2019-05-08 |
| MX2019000213A (en) | 2019-05-13 |
| WO2018006059A1 (en) | 2018-01-04 |
| EP3478792A1 (en) | 2019-05-08 |
| US10703971B2 (en) | 2020-07-07 |
| US20190161675A1 (en) | 2019-05-30 |
| JP2022093395A (en) | 2022-06-23 |
| JP2019530429A (en) | 2019-10-24 |
| JP7426194B2 (en) | 2024-02-01 |
| CA3029241A1 (en) | 2018-01-04 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| SG11201811579VA (en) | Chemiluminescent substrates | |
| SG11201809857TA (en) | Anti-CTLA-4 Antibodies | |
| SG11201903480TA (en) | Cell culture device system and methods of use thereof | |
| SG11201807252QA (en) | Anti-lag-3 antibodies | |
| SG11201804915RA (en) | Methods for treating huntington's disease | |
| SG11201805493YA (en) | Binding members with altered diversity scaffold domains | |
| SG11201901996UA (en) | Formulations of ( r)-2-amino-3-phenylpropyl carbamate | |
| SG11201809499UA (en) | Processes for preparing phosphorodiamidate morpholino oligomers | |
| SG11201900634VA (en) | Chimeric antigen receptor | |
| SG11201908171TA (en) | Compounds and compositions for treating hematological disorders | |
| SG11201803933PA (en) | Optical metrology of lithographic processes using asymmetric sub-resolution features to enhance measurement | |
| SG11201807474SA (en) | Compositions comprising coformulation of anti-pd-l1 and anti-ctla-4 antibodies | |
| SG11201803703UA (en) | Anti-complement factor c1q fab fragments and uses thereof | |
| SG11201809908TA (en) | Stabilized glycopeptide antibiotic formulations | |
| SG11201808713YA (en) | Ophthalmic compositions comprising levodopa, an antioxidant and an aqueous carrier | |
| SG11201809024UA (en) | Cancer immunotherapy by immune activation or immune modulation via globo series antigens | |
| SG11201810411VA (en) | Metamaterial split ring resonator, metamaterial split ring resonator array and energy harvesting apparatus | |
| SG11201809594WA (en) | Nicotine particles and compositions | |
| SG11201805149XA (en) | Compositions comprising 15-hepe and methods of using the same | |
| SG11201809875VA (en) | Compositions and methods for treating spinal muscular atrophy | |
| SG11201806570SA (en) | Barrier composites | |
| SG11201811686UA (en) | 18f-labeled triazole containing psma inhibitors | |
| SG11201805204WA (en) | Nicotine particle capsule | |
| SG11201900123TA (en) | Compositions and methods for treating frontotemporal dementia | |
| SG11201809474TA (en) | Compositions and methods for bioengineered tissues |